Uranium Participation Corporation Completes C$57.6 Million Bought Deal Equity Financing

TORONTO, ONTARIO--(Marketwired - Feb. 6, 2014) -

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

Uranium Participation Corporation (TSX:U) (the "Company" or "Uranium Participation Corp.") is pleased to announce the closing of its bought deal equity offering of 10,522,500 common shares of the Company at a price of $5.47 per common share, which included the exercise in full of the over-allotment option granted to the underwriters, for gross proceeds of $57,558,000.

The offering was underwritten by a syndicate led by Cormark Securities Inc. and included Raymond James Ltd., Cantor Fitzgerald Canada Corporation, RBC Capital Markets and Scotia Capital Inc.

The proceeds of the Offering will be used to fund the purchase of uranium and to fund the ongoing obligations of Uranium Participation Corp. At least 85% of the gross proceeds from the sale of securities by the Corporation must be invested in, or held for future purchases of uranium.

Caution Regarding Forward-Looking Information

This press release contains certain forward-looking statements and forward-looking information that are based on Uranium Participation Corp.'s current internal expectations, estimates, projections, assumptions and beliefs. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may", "will", "expect", "intent", "estimate", "anticipate", "plan", "should", "believe" or "continue" or the negative thereof or variations thereon or similar terminology and include statements with respect to the use of proceeds.

By their very nature, forward-looking statements involve numerous factors, assumptions and estimates. A variety of factors, many of which are beyond the control of Uranium Participation Corp., may cause actual results to differ materially from the expectations expressed in the forward-looking statements. These factors include, but are not limited to, changes in commodity prices and foreign exchange, and the fact that there is no specific time frame under which the Corporation must purchase uranium. For a description of the principal risks of Uranium Participation Corp., see "Risk Factors" in Uranium Participation Corp.'s Short Form Prospectus dated January 29, 2014, a copy of which is available at www.sedar.com.

These and other factors should be considered carefully, and readers are cautioned not to place undue reliance on these forward-looking statements. Although management reviews the reasonableness of its assumptions and estimates, unusual and unanticipated events may occur which render them inaccurate. Under such circumstances, future performance may differ materially from those expressed or implied by the forward-looking statements. Except where required under applicable securities legislation, Uranium Participation Corp. does not undertake to update any forward-looking information statement.

About Uranium Participation Corporation

Uranium Participation Corp. is a company that invests substantially all of its assets in uranium oxide in concentrates (U₃O₈) and uranium hexafluoride (UF₆) (collectively "uranium"), with the primary investment objective of achieving an appreciation in the value of its uranium holdings through increases in the uranium price. Additional information about Uranium Participation Corp. is available on SEDAR at www.sedar.com and on Uranium Participation Corp.'s website at www.uraniumparticipation.com.

These securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States unless registered under that Act or unless an exemption from registration is available.